retatrutide low energy How Does Make You Lose Weight? The Science of the "Triple G" Agonist Retatrutide Triple Agonist (GLP-1/GIP/GCG) |

Understanding the precise mechanism by which GLP-1 agonists work is essential when evaluating whether other compounds, such as berberine, share similar pharmacological properties

A microRNA cluster controls fat cell differentiation and adipose tissue expansion by regulating SNCG

More recent Phase 3 data from the REDEFINE 1 trial showed Cagrilintide monotherapy producing 11.8% weight loss over 68 weeks

These may include nausea, vomiting, diarrhea, and mild gastrointestinal discomfort

"The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: A systematic review and meta-analysis of randomized controlled trials." Clin Nutr ESPEN

Novo Nordisk filed its New Drug Application with the FDA on 18 December 2025, based on data from the REDEFINE 1 trial